Viralgen announces planned CEO succession
DONOSTIA / SAN SEBASTIÁN, Spain, Oct. 19, 2026 /PRNewswire/ — Viralgen, a leading contract development and manufacturing organization (CDMO) specializing in adeno-associated virus (AAV) gene therapy manufacturing, a subsidiary of AskBio, Inc. within
